<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-048051</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Bullous pemphigoid related to PUVA therapy: Two further cases</dc:title>
<dc:description xml:lang="en">Bullous pemphigoid is an autoimmune disease that generally affects elderly people and is characterised by the development of subepidermal blistering.         Although bullous pemphigoid is potentially photosensitive, its occurrence during the treatment course with PUVA, especially in patients with psoriasis, has exceptionally been described.         The association of bullous pemphigoid and psoriasis gives rise to difficulties when initiating treatment and we consider that the use of methotrexate, with or without associated corticoids, is a good alternative in the management of such patients.         We report two further cases of bullous pemphigoid related to PUVA therapy in patients with psoriasis</dc:description>
<dc:creator>Arregui, M. A</dc:creator>
<dc:creator>González, R</dc:creator>
<dc:creator>Tamayo, C</dc:creator>
<dc:creator>Soloeta, R</dc:creator>
<dc:creator>García, I</dc:creator>
<dc:creator>Trébol, I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El penfigoide ampolloso es una enfermedad de etiología autoinmune caracterizada por el desarrollo de ampollas subepidérmicas, que afecta generalmente a personas de edad avanzada.         A pesar de que el penfigoide ampolloso tiene un potencial carácter fotosensible, se ha descrito de forma excepcional el desarrollo de dicho proceso en el curso de tratamiento con PUVA, sobre todo en pacientes con psoriasis.         La asociación de penfigoide ampolloso y psoriasis plantea dificultad a la hora de instaurar un tratamiento y consideramos una buena alternativa la utilización de metotrexate, con o sin corticoides asociados, en el manejo de dichos pacientes.         Aportamos dos nuevos casos de penfigoide ampolloso relacionado con tratamiento con PUVA en pacientes con psoriasis</dc:description>
<dc:source>Actas Dermosifiliogr;97(7): 444-447, sept. 2006. ilus</dc:source>
<dc:identifier>ibc-048051</dc:identifier>
<dc:title xml:lang="es">Penfigoide ampolloso relacionado con tratamiento con PUVA: aportación de dos nuevos casos</dc:title>
<dc:subject>^d308^s22073</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29502^s22016</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d29502^s22067</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d12002^s22012</dc:subject>
<dc:subject>^d12002^s22067</dc:subject>
<dc:subject>^d12137^s22074</dc:subject>
<dc:subject>^d12137^s22045</dc:subject>
<dc:subject>^d12137^s22066</dc:subject>
<dc:subject>^d11207^s22074</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d32748^s22045</dc:subject>
<dc:subject>^d11207^s22066</dc:subject>
<dc:subject>^d10987^s22045</dc:subject>
<dc:subject>^d11207^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>200609</dc:date>
</metadata>
</record>
</ibecs-document>
